世界の臍帯血(UCB)幹細胞市場2022~2026:製薬、研究機関、病院、バイオバンク

■ 英語タイトル:Global Stem Cell Umbilical Cord Blood (UCB) Market 2022-2026

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR74306-22)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR74306-22
■ 発行日:2022年9月6日
■ 調査対象地域:北米、アジア、ヨーロッパ、その他地域
■ 産業分野:バイオ
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の臍帯血(UCB)幹細胞市場2022~2026:製薬、研究機関、病院、バイオバンク]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Technavio社の調査レポートによると、世界の臍帯血(UCB)幹細胞市場規模は2022年から2026年まで年平均16.87% 成長し、14.7億ドルに達する見込みです。本書では、臍帯血(UCB)幹細胞の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(製薬、研究機関、病院、バイオバンク)分析、顧客状況、地域別状況(北米、アジア、ヨーロッパ、アメリカ、中国、ドイツ、イギリス、日本)分析、推進要因・課題・動向、企業状況、企業分析など、多面的に分析を行っています。本書には、主要プレイヤーとしてAmericord Registry LLC、Athersys Inc.、CBR Systems Inc.、Cells4Life Group LLP、Celularity Inc.、Cordlife Group Ltd.、Cryo Cell International Inc.、Cryo Stemcell、Cryoviva Biotech Pvt. Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の臍帯血(UCB)幹細胞市場規模:エンドユーザー別
- 製薬における市場規模2022-2026
- 研究機関における市場規模2022-2026
- 病院における市場規模2022-2026
- バイオバンクにおける市場規模2022-2026
・顧客状況
・地域別状況
- 北米の臍帯血(UCB)幹細胞市場規模2022-2026
- アジアの臍帯血(UCB)幹細胞市場規模2022-2026
- ヨーロッパの臍帯血(UCB)幹細胞市場規模2022-2026
- アメリカの臍帯血(UCB)幹細胞市場規模2022-2026
- 中国の臍帯血(UCB)幹細胞市場規模2022-2026
- ドイツの臍帯血(UCB)幹細胞市場規模2022-2026
- イギリスの臍帯血(UCB)幹細胞市場規模2022-2026
- 日本の臍帯血(UCB)幹細胞市場規模2022-2026
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

Global Stem Cell Umbilical Cord Blood (UCB) Market 2022-2026

Technavio has been monitoring the stem cell umbilical cord blood (UCB) market and it is poised to grow by $1.47 bn during 2022-2026, accelerating at a CAGR of 16.87% during the forecast period. Our report on the stem cell umbilical cord blood (UCB) market provides a holistic analysis of market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of several chronic disorders, increased federal investment in stem cell therapy, and the advent of cord blood banking.

The stem cell umbilical cord blood (UCB) market analysis includes the end-user segment and geographic landscape.
Technavio’s stem cell umbilical cord blood (UCB) market is segmented as below:

By End-user
• Pharmaceutical
• Research institutes
• Hospitals
• Biobanks

By Geographical Landscape
• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the increasing investments in the field of regenerative medicines as one of the prime reasons driving the stem cell umbilical cord blood (UCB) market growth during the next few years. Also, increasing awareness, associated research, and potential clinical applications for stem cell and the rising emergence of personalized medicine will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the stem cell umbilical cord blood (UCB) market covers the following areas:
• Stem cell umbilical cord blood (UCB) market sizing
• Stem cell umbilical cord blood (UCB) market forecast
• Stem cell umbilical cord blood (UCB) market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stem cell umbilical cord blood (UCB) market vendors that include Americord Registry LLC, Athersys Inc., CBR Systems Inc., Cells4Life Group LLP, Celularity Inc., Cordlife Group Ltd., Cryo Cell International Inc., Cryo Stemcell, Cryoviva Biotech Pvt. Ltd., FamiCord Group, FUTURE CELL JAPAN, Global Cord Blood Corp., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., Next Biosciences Pty Ltd., Regrow Biosciences Pvt Ltd., Smart Cells International Ltd., Smith and Nephew plc, ViaCord LLC, and Vita 34 International AG. Also, the stem cell umbilical cord blood (UCB) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 24: Chart on End-user – Market share 2021-2026 (%)
o Exhibit 25: Data Table on End-user – Market share 2021-2026 (%)
o 5.2 Comparison by End-user
o Exhibit 26: Chart on Comparison by End-user
o Exhibit 27: Data Table on Comparison by End-user
o 5.3 Pharmaceutical – Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharmaceutical – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharmaceutical – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharmaceutical – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharmaceutical – Year-over-year growth 2021-2026 (%)
o 5.4 Research Institutes – Market size and forecast 2021-2026
o Exhibit 32: Chart on Research Institutes – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Research Institutes – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Research Institutes – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Research Institutes – Year-over-year growth 2021-2026 (%)
o 5.5 Hospitals – Market size and forecast 2021-2026
o Exhibit 36: Chart on Hospitals – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Hospitals – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Hospitals – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Hospitals – Year-over-year growth 2021-2026 (%)
o 5.6 Biobanks – Market size and forecast 2021-2026
o Exhibit 40: Chart on Biobanks – Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Biobanks – Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Biobanks – Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Biobanks – Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by End-user
o Exhibit 44: Market opportunity by End-user ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 50: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.5 Europe – Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 66: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 China – Market size and forecast 2021-2026
o Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.9 Germany – Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.10 UK – Market size and forecast 2021-2026
o Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.11 Japan – Market size and forecast 2021-2026
o Exhibit 82: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Americord Registry LLC
o Exhibit 93: Americord Registry LLC – Overview
o Exhibit 94: Americord Registry LLC – Product / Service
o Exhibit 95: Americord Registry LLC – Key offerings
o 10.4 CBR Systems Inc.
o Exhibit 96: CBR Systems Inc. – Overview
o Exhibit 97: CBR Systems Inc. – Product / Service
o Exhibit 98: CBR Systems Inc. – Key offerings
o 10.5 Celularity Inc.
o Exhibit 99: Celularity Inc. – Overview
o Exhibit 100: Celularity Inc. – Product / Service
o Exhibit 101: Celularity Inc. – Key news
o Exhibit 102: Celularity Inc. – Key offerings
o 10.6 Cordlife Group Ltd.
o Exhibit 103: Cordlife Group Ltd. – Overview
o Exhibit 104: Cordlife Group Ltd. – Business segments
o Exhibit 105: Cordlife Group Ltd. – Key offerings
o Exhibit 106: Cordlife Group Ltd. – Segment focus
o 10.7 Cryo Cell International Inc.
o Exhibit 107: Cryo Cell International Inc. – Overview
o Exhibit 108: Cryo Cell International Inc. – Business segments
o Exhibit 109: Cryo Cell International Inc. – Key offerings
o Exhibit 110: Cryo Cell International Inc. – Segment focus
o 10.8 Global Cord Blood Corp.
o Exhibit 111: Global Cord Blood Corp. – Overview
o Exhibit 112: Global Cord Blood Corp. – Product / Service
o Exhibit 113: Global Cord Blood Corp. – Key offerings
o 10.9 LifeCell International Pvt. Ltd.
o Exhibit 114: LifeCell International Pvt. Ltd. – Overview
o Exhibit 115: LifeCell International Pvt. Ltd. – Product / Service
o Exhibit 116: LifeCell International Pvt. Ltd. – Key offerings
o 10.10 MEDIPOST Co. Ltd.
o Exhibit 117: MEDIPOST Co. Ltd. – Overview
o Exhibit 118: MEDIPOST Co. Ltd. – Product / Service
o Exhibit 119: MEDIPOST Co. Ltd. – Key offerings
o 10.11 ViaCord LLC
o Exhibit 120: ViaCord LLC – Overview
o Exhibit 121: ViaCord LLC – Product / Service
o Exhibit 122: ViaCord LLC – Key offerings
o 10.12 Vita 34 International AG
o Exhibit 123: Vita 34 International AG – Overview
o Exhibit 124: Vita 34 International AG – Business segments
o Exhibit 125: Vita 34 International AG – Key offerings
o Exhibit 126: Vita 34 International AG – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by End-user
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on End-user – Market share 2021-2026 (%)
Exhibits25: Data Table on End-user – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by End-user
Exhibits27: Data Table on Comparison by End-user
Exhibits28: Chart on Pharmaceutical – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharmaceutical – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharmaceutical – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharmaceutical – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Research Institutes – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Research Institutes – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Research Institutes – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Research Institutes – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Hospitals – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Hospitals – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Hospitals – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Hospitals – Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Biobanks – Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Biobanks – Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Biobanks – Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Biobanks – Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by End-user ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Americord Registry LLC – Overview
Exhibits94: Americord Registry LLC – Product / Service
Exhibits95: Americord Registry LLC – Key offerings
Exhibits96: CBR Systems Inc. – Overview
Exhibits97: CBR Systems Inc. – Product / Service
Exhibits98: CBR Systems Inc. – Key offerings
Exhibits99: Celularity Inc. – Overview
Exhibits100: Celularity Inc. – Product / Service
Exhibits101: Celularity Inc. – Key news
Exhibits102: Celularity Inc. – Key offerings
Exhibits103: Cordlife Group Ltd. – Overview
Exhibits104: Cordlife Group Ltd. – Business segments
Exhibits105: Cordlife Group Ltd. – Key offerings
Exhibits106: Cordlife Group Ltd. – Segment focus
Exhibits107: Cryo Cell International Inc. – Overview
Exhibits108: Cryo Cell International Inc. – Business segments
Exhibits109: Cryo Cell International Inc. – Key offerings
Exhibits110: Cryo Cell International Inc. – Segment focus
Exhibits111: Global Cord Blood Corp. – Overview
Exhibits112: Global Cord Blood Corp. – Product / Service
Exhibits113: Global Cord Blood Corp. – Key offerings
Exhibits114: LifeCell International Pvt. Ltd. – Overview
Exhibits115: LifeCell International Pvt. Ltd. – Product / Service
Exhibits116: LifeCell International Pvt. Ltd. – Key offerings
Exhibits117: MEDIPOST Co. Ltd. – Overview
Exhibits118: MEDIPOST Co. Ltd. – Product / Service
Exhibits119: MEDIPOST Co. Ltd. – Key offerings
Exhibits120: ViaCord LLC – Overview
Exhibits121: ViaCord LLC – Product / Service
Exhibits122: ViaCord LLC – Key offerings
Exhibits123: Vita 34 International AG – Overview
Exhibits124: Vita 34 International AG – Business segments
Exhibits125: Vita 34 International AG – Key offerings
Exhibits126: Vita 34 International AG – Segment focus
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR74306-22 )"世界の臍帯血(UCB)幹細胞市場2022~2026:製薬、研究機関、病院、バイオバンク" (英文:Global Stem Cell Umbilical Cord Blood (UCB) Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。